Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2026-03-10 @ 6:18 PM
Study NCT ID:
NCT02511132
Status:
COMPLETED
Last Update Posted:
2022-12-22
First Post:
2015-07-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma
Sponsor:
Organization: